{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:55:49Z","timestamp":1764402949964,"version":"build-2065373602"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.053","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T01:28:45Z","timestamp":1573781325000},"page":"608-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children \u2013 A systematic review and a meta-analysis"],"prefix":"10.1016","volume":"38","author":[{"given":"Manish M.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Beacham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela P.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Lafond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0483-9941","authenticated-orcid":false,"given":"Melissa","family":"Rolfes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-1649","authenticated-orcid":false,"given":"Min Z.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Azziz-Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0046-3147","authenticated-orcid":false,"given":"Mark G.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia M.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.053_b0005","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/INF.0000000000000321","article-title":"The burden of influenza hospitalizations in infants from 2003 to 2012, United States","volume":"33","author":"Chaves","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.053_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001977","article-title":"Global role and burden of influenza in pediatric respiratory hospitalizations, 1982\u20132012: a systematic analysis","volume":"13","author":"Lafond","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0015","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.10.053_b0020","article-title":"Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis","volume":"5","author":"Shi","year":"2015","journal-title":"J Glob Health"},{"key":"10.1016\/j.vaccine.2019.10.053_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/338363","article-title":"Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study","volume":"185","author":"Neuzil","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.053_b0035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00006454-199711000-00012","article-title":"Influenza virus infections in infants","volume":"16","author":"Glezen","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.053_b0040","first-page":"20143085","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.vaccine.2019.10.053_b0045","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI116526","article-title":"Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages","volume":"91","author":"Clerici","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.10.053_b0050","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMc0912599","article-title":"Influenza immunization in pregnancy\u2013antibody responses in mothers and infants","volume":"362","author":"Steinhoff","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0055","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/CVI.00396-10","article-title":"Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands","volume":"18","author":"Bodewes","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.10.053_b0060","first-page":"19","article-title":"Prevalence of antibodies against influenza A and B viruses in children in Germany, 2008 to 2010","volume":"2014","author":"Sauerbrei","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2019.10.053_b0065","first-page":"684","article-title":"Risk factors of influenza transmission in households","volume":"54","author":"Viboud","year":"2004","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.vaccine.2019.10.053_b0070","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jama.1980.03300390029017","article-title":"Influenza in children. Relationship to other respiratory agents","volume":"243","author":"Glezen","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.10.053_b0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.inf.0000253062.41648.60","article-title":"Influenza burden in febrile infants and young children in a pediatric emergency department","volume":"26","author":"Ploin","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.053_b0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.ph.46.030184.003153","article-title":"Fetal and postnatal development of the lung","volume":"46","author":"Burri","year":"1984","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.vaccine.2019.10.053_b0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0378-3782(77)90041-X","article-title":"The functional growth and development of the lung during the first year of life","volume":"1","author":"Stocks","year":"1977","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.vaccine.2019.10.053_b0090","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4313","article-title":"What have we learned about influenza deaths in children and how can we do better?","volume":"141","author":"Edwards","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.10.053_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6703a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices-united states, 2018\u201319 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2019.10.053_b0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2213-2600(18)30138-3","article-title":"How do we best prevent influenza in young children?","volume":"6","author":"Neuzil","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/INF.0000000000001006","article-title":"Influenza vaccine effectiveness for fully and partially vaccinated children 6 months to 8 years old during 2011\u20132012 and 2012\u20132013: the importance of two priming doses","volume":"35","author":"Thompson","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.053_b0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/INF.0b013e31819219b8","article-title":"Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children","volume":"28","author":"Bracco Neto","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.053_b0115","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/507309","article-title":"Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children","volume":"194","author":"Neuzil","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.053_b0120","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1542\/peds.2006-0201","article-title":"Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers","volume":"118","author":"Englund","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.10.053_b0125","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1542\/peds.2006-0198","article-title":"Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?","volume":"118","author":"Walter","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.10.053_b0130","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1542\/peds.69.4.404","article-title":"Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months","volume":"69","author":"Bernstein","year":"1982","journal-title":"Pediatrics"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2019.10.053_b0135","doi-asserted-by":"crossref","first-page":"S616","DOI":"10.1093\/infdis\/136.Supplement_3.S616","article-title":"Reactogenicity and immunogenicity of bivalent influenza vaccine in one- and two-dose trials in children: a summary","volume":"136","author":"Gross","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.053_b0140","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jpeds.2006.09.002","article-title":"Influenza vaccine for young children: two doses are better than one","volume":"149","author":"Neuzil","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2019.10.053_b0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/infdis\/134.6.633","article-title":"From the national institute of allergy and infectious diseases of the national institutes of health, the center for disease control, and the bureau of biologics of the food and drug administration. Summary of clinical trials of influenza vaccines\u2013II","volume":"134","author":"Wright","year":"1976","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.053_b0150","article-title":"Influenza vaccine effectiveness against hospitalization in fully and partially vaccinated children in Israel; 2015\u201316, 2016\u201317, and 2017\u201318","author":"Segaloff","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.053_b0155","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1016\/j.vaccine.2017.06.036","article-title":"Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations \u2013 Latin America, 2013","volume":"36","author":"El Omeiri","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.053_b0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/infdis\/jix634","article-title":"Influence of birth cohort on effectiveness of 2015\u20132016 influenza vaccine against medically attended illness due to 2009 pandemic influenza A(H1N1) virus in the United States","volume":"218","author":"Flannery","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.053_b0165","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.4161\/hv.28313","article-title":"Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50\u201380 years of age","volume":"10","author":"Ross","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.053_b0170","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nm.4248","article-title":"Understanding immune responses to the influenza vaccine","volume":"22","author":"Webby","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0175","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.053_b0180","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1016\/j.vaccine.2011.07.093","article-title":"Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses","volume":"29","author":"Lanthier","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.053_b0185","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0190","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1073\/pnas.1519690113","article-title":"Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood","volume":"113","author":"Nakaya","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.10.053_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095496","article-title":"Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization","volume":"9","author":"Khurana","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.10.053_b0200","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1073\/pnas.1525361113","article-title":"Systems vaccinology informs influenza vaccine immunogenicity","volume":"113","author":"Garcia-Sastre","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.10.053_b0205","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0210","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/infdis\/173.6.1313","volume":"173","author":"Gruber","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.053_b0215","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/infdis\/169.5.1121","article-title":"Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children","volume":"169","author":"Swierkosz","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.053_b0220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/INF.0b013e31819d6394","article-title":"Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.053_b0225","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1016\/j.vaccine.2009.02.004","article-title":"MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination","volume":"27","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.053_b0230","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3855\/jidc.4594","article-title":"Safety and immunogenicity profiles of an adjuvanted seasonal influenza vaccine in Guatemalan children","volume":"8","author":"Solares","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2019.10.053_b0235","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1016\/j.vaccine.2011.08.111","article-title":"Trivalent and quadrivalent MF59((R))-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study","volume":"29","author":"Della Cioppa","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.053_b0240","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children","volume":"365","author":"Vesikari","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0245","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1080\/21645515.2015.1044167","article-title":"Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine","volume":"11","author":"Vesikari","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.053_b0250","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1016\/j.vaccine.2014.08.068","article-title":"Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children","volume":"32","author":"Nolan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.053_b0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/INF.0000000000000465","article-title":"Dissecting the immune response to MF59-adjuvanted and nonadjuvanted seasonal influenza vaccines in children less than three years of age","volume":"34","author":"Zedda","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.053_b0260","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1016\/j.vaccine.2018.08.032","article-title":"Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naive children in a randomized clinical trial in rural Senegal","volume":"36","author":"Diallo","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.053_b0265","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S2213-2600(18)30108-5","article-title":"Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial","volume":"6","author":"Vesikari","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0270","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/21645515.2017.1373227","article-title":"MF59-adjuvanted influenza vaccine (FLUAD(R)) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone(R)): a randomized, multicenter, Phase III pediatric trial in Mexico","volume":"14","author":"Cruz-Valdez","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.053_b0275","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/pch\/pxx189","article-title":"Vaccine recommendations for children and youth for the 2017\/2018 influenza season","volume":"23","author":"Moore","year":"2018","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2019.10.053_b0280","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.10.053_b0285","first-page":"1525","article-title":"Comparative Immunogenicity of Enhanced Seasonal Influenza Vaccines in Older Adults: a systematic review and meta-analysis","volume":"219","author":"Ng","year":"2019","journal-title":"J Infect Dis"},{"year":"2001","series-title":"Statistical inference","author":"Casella","key":"10.1016\/j.vaccine.2019.10.053_b0290"},{"key":"10.1016\/j.vaccine.2019.10.053_b0295","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071079","article-title":"Does raising type 1 error rate improve power to detect interactions in linear regression models? A simulation study","volume":"8","author":"Durand","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.10.053_b0305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-5573-4-4","article-title":"Power for tests of interaction: effect of raising the Type I error rate","volume":"4","author":"Marshall","year":"2007","journal-title":"Epidemiol Perspect Innov"},{"key":"10.1016\/j.vaccine.2019.10.053_b0310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMc1113381","article-title":"Influenza vaccine in young children","volume":"366","author":"Ambrose","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0315","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1056\/NEJMc1205643","article-title":"Committee for Medicinal Products for Human Use EMA. More on influenza vaccine in young children","volume":"366","author":"Sancho","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.053_b0320","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.vaccine.2015.12.024","article-title":"A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children","volume":"34","author":"Stassijns","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.053_b0325","unstructured":"Available at: https:\/\/www.novartis.ca\/sites\/www.novartis.ca\/files\/fluad_scrip_e%202016.pdf (Last accessed, 19 April 2019)."},{"key":"10.1016\/j.vaccine.2019.10.053_b0330","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1073\/pnas.0903181106","article-title":"Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.10.053_b0335","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1080\/21645515.2018.1495301","article-title":"Immunology and efficacy of MF59-adjuvanted vaccines","volume":"14","author":"Ko","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.053_b0340","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.11.23","article-title":"MF59 adjuvant: the best insurance against influenza strain diversity","volume":"10","author":"O'Hagan","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.10.053_b0345","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.053_b0350","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vaccine.2011.10.062","article-title":"Antibody persistence and response to 2010\u20132011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children","volume":"30","author":"Gilca","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.053_b0355","first-page":"9","article-title":"Time to change dosing of inactivated quadrivalent influenza vaccine in young children: evidence from a Phase III, randomized, controlled trial","volume":"6","author":"Jain","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2019.10.053_b0360","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/296115a0","article-title":"Molecular mechanisms of variation in influenza viruses","volume":"296","author":"Webster","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.10.053_b0365","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1073\/pnas.0804699105","article-title":"Molecular and cellular signatures of human vaccine adjuvants","volume":"105","author":"Mosca","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.10.053_b0370","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Seubert","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.10.053_b0375","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.vaccine.2010.12.090","article-title":"Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes","volume":"29","author":"Calabro","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.053_b0380","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/21645515.2017.1413518","article-title":"The establishment of surrogates and correlates of protection: useful tools for the licensure of effective influenza vaccines?","volume":"14","author":"Ward","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.053_b0385","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/eri.11.51","article-title":"Serologic assays for influenza surveillance, diagnosis and vaccine evaluation","volume":"9","author":"Katz","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.vaccine.2019.10.053_b0390","doi-asserted-by":"crossref","first-page":"13371","DOI":"10.1128\/JVI.01426-12","article-title":"Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors","volume":"86","author":"Zhu","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.053_b0395","unstructured":"World Health Organization (WHO) Manual for the laboratory diagnosis and virological surveillance of influenza, 2011. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44518\/9789241548090_eng.pdf;jsessionid=421FC109685ACACA072B1E56EBFC2480?sequence=1 (Last accessed, 19 April 2019)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:46Z","timestamp":1759401586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19314331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19314331"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children \u2013 A systematic review and a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}